novo nordisk semaglutide direct faces 'must-win' battle over U.S. Wegovy, Ozempic in 2026 Novo Nordisk's semaglutide shows promise

The FDA label for Wegovy reports nausea in approximately 44% of patients, while Ozempic has lower rates (around 15-20%)

A brief diet intervention can reduce symptoms of depression in young adultsA randomised controlled trial

00:01:45 Vickie Danaher But this means that we now have multiple different FDA approved semaglutide products that we may get prescriptions for or that our patients may be getting or asking about

Metabolic Dysfunction and Weight Resistance: By stimulating the L-cells in the lower intestine to naturally secrete GLP-1, the microbiome fermentation process helps regulate insulin sensitivity, suppress excess glucagon, and promote natural satiety signals to the brain

Molecular Metabolism, 30 , 72-130

By connecting clinical data and preferences in real time, we can anticipate needs and guide each person to the right support, through the right channel, at the right moment